<DOC>
	<DOCNO>NCT02271958</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety 2.5 , 5 10 mg dos mifepristone placebo woman laparoscopic diagnostic endometriosis . The hypothesis study 5 mg mifepristone dose safe effective use future study medical treatment endometriosis .</brief_summary>
	<brief_title>Mifepristone 2.5 , 5 , 10 mg Versus Placebo Treatment Endometriosis</brief_title>
	<detailed_description>This double-blind randomized clinical trial . Examinations undertaken Thorough gynecological examination , pelvic ultrasound examination , diagnostic laparoscopy start treatment order determine localization , extent degree severity endometrial lesion score assigned accordance revise American Fertility Society ( AFS ) classification.19 Blood sample take hematological test hepatic function . Endometrial biopsy perform endometrial thickness calibrate ultrasound &gt; 8 mm abnormal bleeding past 3 month . After 90 180 day treatment ultrasound examination pelvis carry followed diagnostic-therapeutic laparoscopy endometrial biopsy . Subjects Women laparoscopic confirm diagnosis endometriosis volunteer take part study . Inclusion criterion : ) age 18 45 , b ) certain diagnosis endometriosis degree correspond American Fertility Society ( AFS ) ; c ) patient symptoms endometriosis : dysmenorrhea pelvic pain attributable gynecological illness ) acceptance use barrier contraceptive method study . Exclusion criterion : ) breastfeeding , b ) hormonal surgical treatment endometriosis le 4 month previous study , c ) diabetes , ) severe arterial hypertension , e ) hepatopathy , f ) renal malfunction , g ) endocrinopathy , f ) contraindication regard use antiprogestins .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Women laparoscopic confirm diagnosis endometriosis Age 18 45 Certain diagnosis endometriosis degree correspond American Fertility Society ( AFS ) Patients symptoms endometriosis : dysmenorrhea pelvic pain attributable gynecological illness Acceptance use barrier contraceptive method study Breastfeeding Hormonal surgical treatment endometriosis le 4 month previous study Diabetes Severe arterial hypertension Hepatopathy Renal malfunction Endocrinopathy Any contraindication regard use antiprogestins .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Mifepristone</keyword>
	<keyword>Endometriosis</keyword>
</DOC>